top
Search terms
Results 1 - 9 of 9 - ordered by :
Ehjournal

Introduction Controversy exists as to the existence of a gender bias in the use of fibrinolysis and invasive procedures for acute myocardial infarction (AMI) in eligible women.19 Nevertheless, prior ...

European Heart Journal, Tjandrawidjaja, Michael C., Fu, Yuling, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher B., Armstrong, Paul W.

Date : 01/06/2003
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146465 bytes
Ehjournal

MR severity, quantified as the regurgitant jet area/left atrial area ratio, was assessed at baseline, one and 20 months post-MI and related to LV size, shape, function, and clinical ...

European Heart Journal, Amigoni, Maria, Meris, Alessandra, Thune, Jens Jakob, Mangalat, Deepa, Skali, Hicham, Bourgoun, Mikhail, Warnica, J. Wayne, Barvik, Stale, Arnold, J. Malcolm O., Velazquez, ...

Date : 01/02/2007 Item size : 294897 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 146421 bytes
Ehjournal

Introduction Controversy exists as to the existence of a gender bias in the use of fibrinolysis and invasive procedures for acute myocardial infarction (AMI) in eligible women.19 Nevertheless, prior ...

European Heart Journal, Tjandrawidjaja, Michael C., Fu, Yuling, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher B., Armstrong, Paul W.

Date : 01/06/2003 Item size : 186601 bytes
Ehjournal

Abstract Aims ASSENT 3 (Assessment of the Safety and Efficacy of a New Thrombolytic) demonstrated that the bolus fibrinolytic tenecteplase (TNK), combined with enoxaparin (ENOX) or abciximab (ABCX), ...

European Heart Journal, Armstrong, Paul W., Wagner, Galen, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher, Wallentin, Lars, Fu, Yuling

Date : 01/08/2003 Item size : 183515 bytes
Ehjournal

The current ESC and ACC/AHA guidelines advocate greater than 50% resolution of ST-segment elevation at 6090 min following fibrinolysis as a marker of successful reperfusion.1,2 This metric is also ...

European Heart Journal, Tjandrawidjaja, Michael C., Fu, Yuling, Westerhout, Cynthia M., White, Harvey D., Todaro, Thomas G., Van de Werf, Frans, Mahaffey, Kenneth W., Wagner, Galen S., Granger, ...

Date : 01/03/2010 Item size : 301978 bytes
Ehjournal

Combined analysis of the GUSTO-I and III trials have shown that women are significantly more likely than men to sustain early reinfarction.20 Accordingly, the large ASSENT-2 (Assessment of the Safety ...

European Heart Journal, Tjandrawidjaja, Michael C., Fu, Yuling, Goodman, Shaun G., Van de Werf, Frans, Granger, Christopher B., Armstrong, Paul W.

Date : 01/06/2003 Item size : 220136 bytes
Ehjournal

MR severity, quantified as the regurgitant jet area/left atrial area ratio, was assessed at baseline, one and 20 months post-MI and related to LV size, shape, function, and clinical ...

European Heart Journal, Amigoni, Maria, Meris, Alessandra, Thune, Jens Jakob, Mangalat, Deepa, Skali, Hicham, Bourgoun, Mikhail, Warnica, J. Wayne, Barvik, Stale, Arnold, J. Malcolm O., Velazquez, ...

Date : 01/02/2007